Viewing Study NCT07349069


Ignite Creation Date: 2026-03-26 @ 3:17 PM
Ignite Modification Date: 2026-03-31 @ 10:58 AM
Study NCT ID: NCT07349069
Status: RECRUITING
Last Update Posted: 2026-03-19
First Post: 2026-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With High-Risk Early Breast Cancer
Sponsor: Shandong Suncadia Medicine Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module